Home>
US Stocks>
Apellis Pharmaceuticals

Apellis Pharmaceuticals share price today

(APLS)

Apellis Pharmaceuticals share price is $33.32 & ₹2,838.80 as on 25 Dec 2024, 2.30 'hrs' IST

$33.32

▲

0.11

(0.33%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Apellis Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Apellis Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Apellis Pharmaceuticals. Get details on the Indian mutual funds that are investing in Apellis Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Apellis Pharmaceuticals's financials.

Apellis Pharmaceuticals share price movements

Today's Low: $32.56
Today's High: $33.36
$33.32
2.3%
Downside
Day's Volatility :2.4%
Upside
0.1%
52 Weeks Low: $24.34
52 Weeks High: $73.80
$33.32
26.95%
Downside
52 Weeks Volatility :67.02%
Upside
54.85%

Apellis Pharmaceuticals Returns

Period	Apellis Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	11.62%	-9.0%	0.0%
6 Months	-19.75%	-4.6%	0.0%
1 Year	-47.06%	3.0%	0.0%
3 Years	-30.35%	0.0%	-21.1%

Apellis Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$33.21
Open	$33.21
Today's High	$33.355
Today's Low	$32.555
Market Capitalization	$4.1B
Today's Volume	$437.3K
52 Week High	$73.8
52 Week Low	$24.34
Revenue TTM	$715.2M
EBITDA	$-221.5M
Earnings Per Share (EPS)	$-2.03
Profit Margin	-34.97%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-106.56%

How to invest in Apellis Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Apellis Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Apellis Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Apellis Pharmaceuticals or APLS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Apellis Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Apellis Pharmaceuticals shares which would translate to 0.026 fractional shares of Apellis Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Apellis Pharmaceuticals, in just a few clicks!

Returns in Apellis Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Apellis Pharmaceuticals investment value today

Current value as on today

₹55,178

Returns

₹44,822

(-44.82%)

Returns from Apellis Pharmaceuticals Stock

₹47,061 (-47.06%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Apellis Pharmaceuticals

-63.77%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Apellis Pharmaceuticals from India has reduced in the last 30 days as on Dec 26, 2024. -63.77% less purchase transactions for Apellis Pharmaceuticals in the last 30 days versus the previous period.

-39%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Apellis Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -39% less investors are searching Apellis Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Apellis Pharmaceuticals

Wellington Management Company LLP
12.51%
EcoR1 Capital, LLC
9.56%
venBio Select Advisor LLC
8.93%
Vanguard Group Inc
7.89%
BlackRock Inc
4.66%
Deep Track Capital, LP
3.54%

Analyst Recommendation on Apellis Pharmaceuticals

Buy

82%Buy

17%Hold

0%Sell

Based on 23 Wall street analysts offering stock ratings for Apellis Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 23 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Apellis Pharmaceuticals

What analysts predicted

Upside of 37.3%

Current:

$33.32

Target:

$45.75

Insights on Apellis Pharmaceuticals

Price Movement
In the last 1 year, APLS stock has moved down by -44.6%
Decreasing Revenue
Revenue is down for the last 2 quarters, 199.68M → 196.83M (in $), with an average decrease of 1.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -37.65M → -57.44M (in $), with an average decrease of 52.6% per quarter
APLS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 71.8%
APLS vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 57.4%
Price to Sales
ForAPLS every $1 of sales, investors are willing to pay $5.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Apellis Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Apellis Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Apellis Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Apellis Pharmaceuticals Inc	2.11%	-19.75%	-47.06%	-30.35%	12.91%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Apellis Pharmaceuticals Inc	NA	NA	NA	-1.67	-1.07	-0.16	NA	1.94
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Apellis Pharmaceuticals Inc	Buy	$4.1B	12.91%	NA	-34.97%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

Apellis Pharmaceuticals Dividend announcements

Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals’s price-to-earnings ratio stands at None
Read More

About Apellis Pharmaceuticals

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Organization	Apellis Pharmaceuticals
Employees	702
CEO	Dr. Cedric Francois M.D., Ph.D.
Industry	Distribution Services

Management People of Apellis Pharmaceuticals

Name	Title
Dr. Cedric Francois M.D., Ph.D.	Co-Founder, President, CEO & Director
Mr. Alec Machiels J.D., MBA	Co-Founder & Director
Mr. Timothy E. Sullivan	CFO & Treasurer
Mr. Adam J. Townsend	Chief Operating Officer
Mr. David O. Watson Esq., J.D.	General Counsel
Dr. Caroline R. Baumal M.D.	Chief Medical Officer
Dr. Pascal Deschatelets Ph.D.	Co-Founder & Chief Scientific Officer
Mr. James G. Chopas CPA	VP, Corporate Controller & Chief Accounting Officer
Ms. Meredith Kaya	Senior Vice President, Investor Relations & Strategic Finance
Ms. Karen Lewis	Chief People Officer

Important FAQs about investing in Apellis Pharmaceuticals from India :

What is Apellis Pharmaceuticals share price today?

Apellis Pharmaceuticals share price today stands at $33.32, Open: $33.21 ; Previous Close: $33.21 ; High: $33.36 ; Low: $32.56 ; 52 Week High: $73.80 ; 52 Week Low: $24.34. The stock opens at $33.21, after a previous close of $33.21. The stock reached a daily high of $33.36 and a low of $32.56, with a 52-week high of $73.80 and a 52-week low of $24.34.

Can Indians buy Apellis Pharmaceuticals shares?

Yes, Indians can invest in the Apellis Pharmaceuticals (APLS) from India.

With INDmoney, you can buy Apellis Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Apellis Pharmaceuticals at zero transaction cost.

How can I buy Apellis Pharmaceuticals shares from India?

It is very easy to buy Apellis Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Apellis Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Apellis Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Apellis Pharmaceuticals stocks?

To start investing in Apellis Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.